Emerging technologies in cardiovascular medicine continue to shape the landscape of patient care. Artificial intelligence (AI) and machine learning algorithms are increasingly integrated into cardiovascular technologies to analyze complex datasets, enhance diagnostic accuracy, and predict patient outcomes. Telemedicine platforms offer remote consultations and monitoring, improving access to specialized cardiovascular care, particularly in underserved or remote areas. 3D printing technology is utilized to create patient-specific models for surgical planning, allowing for more precise interventions. Bioengineering innovations, such as tissue-engineered heart valves and regenerative therapies, hold promise for addressing the limitations of current treatment modalities. As cardiovascular technologies evolve, the field is poised for continued advancements, with a focus on personalized medicine, improved patient outcomes, and the overall optimization of cardiovascular health.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation